Annual Current Liabilities
$12.94 M
+$7.41 M+133.98%
December 31, 2023
Summary
- As of February 26, 2025, CLRB annual total current liabilities is $12.94 million, with the most recent change of +$7.41 million (+133.98%) on December 31, 2023.
- During the last 3 years, CLRB annual current liabilities has risen by +$9.37 million (+263.10%).
- CLRB annual current liabilities is now -23.75% below its all-time high of $16.97 million, reached on December 31, 2009.
Performance
CLRB Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$20.31 M
+$5.15 M+33.93%
September 30, 2024
Summary
- As of February 26, 2025, CLRB quarterly total current liabilities is $20.31 million, with the most recent change of +$5.15 million (+33.93%) on September 30, 2024.
- Over the past year, CLRB quarterly current liabilities has stayed the same.
- CLRB quarterly current liabilities is now -19.89% below its all-time high of $25.36 million, reached on December 31, 2023.
Performance
CLRB Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CLRB Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +134.0% | 0.0% |
| 3 y3 years | +263.1% | +541.7% |
| 5 y5 years | +697.6% | +582.2% |
CLRB Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +224.2% | -19.9% | +409.1% |
| 5 y | 5-year | at high | +367.1% | -19.9% | +633.4% |
| alltime | all time | -23.8% | +5856.5% | -19.9% | >+9999.0% |
Cellectar Biosciences Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $20.31 M(+33.9%) |
| Jun 2024 | - | $15.17 M(-6.8%) |
| Mar 2024 | - | $16.27 M(-35.8%) |
| Dec 2023 | $12.94 M(+134.0%) | $25.36 M(+54.0%) |
| Sep 2023 | - | $16.47 M(+155.5%) |
| Jun 2023 | - | $6.45 M(-7.3%) |
| Mar 2023 | - | $6.96 M(-39.5%) |
| Dec 2022 | $5.53 M(+38.6%) | $11.50 M(+76.5%) |
| Sep 2022 | - | $6.52 M(+16.2%) |
| Jun 2022 | - | $5.61 M(+20.5%) |
| Mar 2022 | - | $4.65 M(+16.6%) |
| Dec 2021 | $3.99 M(+12.0%) | $3.99 M(+26.0%) |
| Sep 2021 | - | $3.17 M(-10.0%) |
| Jun 2021 | - | $3.52 M(-29.9%) |
| Mar 2021 | - | $5.02 M(+40.9%) |
| Dec 2020 | $3.56 M(+28.6%) | $3.56 M(-9.9%) |
| Sep 2020 | - | $3.96 M(+19.2%) |
| Jun 2020 | - | $3.32 M(+8.8%) |
| Mar 2020 | - | $3.05 M(+10.1%) |
| Dec 2019 | $2.77 M(+70.8%) | $2.77 M(-7.0%) |
| Sep 2019 | - | $2.98 M(+11.4%) |
| Jun 2019 | - | $2.67 M(+21.6%) |
| Mar 2019 | - | $2.20 M(+35.6%) |
| Dec 2018 | $1.62 M(-23.3%) | $1.62 M(-39.0%) |
| Sep 2018 | - | $2.66 M(+16.2%) |
| Jun 2018 | - | $2.29 M(+8.6%) |
| Mar 2018 | - | $2.11 M(-0.3%) |
| Dec 2017 | $2.11 M(+29.5%) | $2.11 M(-0.8%) |
| Sep 2017 | - | $2.13 M(+34.2%) |
| Jun 2017 | - | $1.59 M(+13.6%) |
| Mar 2017 | - | $1.40 M(-14.4%) |
| Dec 2016 | $1.63 M(-71.4%) | $1.63 M(+14.5%) |
| Sep 2016 | - | $1.43 M(+2.3%) |
| Jun 2016 | - | $1.39 M(-50.4%) |
| Mar 2016 | - | $2.81 M(-50.7%) |
| Dec 2015 | $5.70 M(-8.5%) | $5.70 M(+4.2%) |
| Sep 2015 | - | $5.48 M(-6.2%) |
| Jun 2015 | - | $5.84 M(-0.9%) |
| Mar 2015 | - | $5.90 M(-5.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $6.23 M(+37.8%) | $6.23 M(+201.8%) |
| Sep 2014 | - | $2.07 M(-49.4%) |
| Jun 2014 | - | $4.08 M(-7.5%) |
| Mar 2014 | - | $4.41 M(-2.6%) |
| Dec 2013 | $4.52 M(+517.3%) | $4.52 M(-2.3%) |
| Sep 2013 | - | $4.63 M(-24.0%) |
| Jun 2013 | - | $6.09 M(-7.6%) |
| Mar 2013 | - | $6.59 M(+799.8%) |
| Dec 2012 | $732.70 K(+45.5%) | $732.70 K(-0.6%) |
| Sep 2012 | - | $736.80 K(+15.9%) |
| Jun 2012 | - | $635.70 K(+25.6%) |
| Mar 2012 | - | $506.30 K(+0.5%) |
| Dec 2011 | $503.60 K(-44.3%) | $503.60 K(-3.5%) |
| Sep 2011 | - | $521.80 K(+16.1%) |
| Jun 2011 | - | $449.50 K(+0.8%) |
| Mar 2011 | - | $446.10 K(-50.7%) |
| Dec 2010 | $904.80 K(-94.7%) | $904.80 K(-85.8%) |
| Sep 2010 | - | $6.37 M(+16.8%) |
| Jun 2010 | - | $5.45 M(-7.1%) |
| Mar 2010 | - | $5.87 M(-65.4%) |
| Dec 2009 | $16.97 M(+156.4%) | $16.97 M(+129.0%) |
| Sep 2009 | - | $7.41 M(-6.2%) |
| Jun 2009 | - | $7.90 M(+59.8%) |
| Mar 2009 | - | $4.94 M(-25.3%) |
| Dec 2008 | $6.62 M(-6.3%) | $6.62 M(-5.0%) |
| Sep 2008 | - | $6.96 M(-15.5%) |
| Jun 2008 | - | $8.24 M(-14.4%) |
| Mar 2008 | - | $9.62 M(+36.3%) |
| Dec 2007 | $7.06 M(+437.5%) | $7.06 M(+48.5%) |
| Sep 2007 | - | $4.75 M(+63.0%) |
| Jun 2007 | - | $2.92 M(+123.1%) |
| Mar 2007 | - | $1.31 M(-0.5%) |
| Dec 2006 | $1.31 M(+504.7%) | $1.31 M(+18.6%) |
| Sep 2006 | - | $1.11 M(+74.3%) |
| Jun 2006 | - | $635.40 K(+33.6%) |
| Mar 2006 | - | $475.60 K(+119.0%) |
| Dec 2005 | $217.20 K | $217.20 K(-68.8%) |
| Sep 2005 | - | $695.60 K(-18.4%) |
| Jun 2005 | - | $852.10 K(+645.5%) |
| Mar 2005 | - | $114.30 K |
FAQ
- What is Cellectar Biosciences annual total current liabilities?
- What is the all time high annual current liabilities for Cellectar Biosciences?
- What is Cellectar Biosciences annual current liabilities year-on-year change?
- What is Cellectar Biosciences quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Cellectar Biosciences?
- What is Cellectar Biosciences quarterly current liabilities year-on-year change?
What is Cellectar Biosciences annual total current liabilities?
The current annual current liabilities of CLRB is $12.94 M
What is the all time high annual current liabilities for Cellectar Biosciences?
Cellectar Biosciences all-time high annual total current liabilities is $16.97 M
What is Cellectar Biosciences annual current liabilities year-on-year change?
Over the past year, CLRB annual total current liabilities has changed by +$7.41 M (+133.98%)
What is Cellectar Biosciences quarterly total current liabilities?
The current quarterly current liabilities of CLRB is $20.31 M
What is the all time high quarterly current liabilities for Cellectar Biosciences?
Cellectar Biosciences all-time high quarterly total current liabilities is $25.36 M
What is Cellectar Biosciences quarterly current liabilities year-on-year change?
Over the past year, CLRB quarterly total current liabilities has changed by $0.00 (0.00%)